Wynholds Kristin Insider Trades

Insider Trading History

Track insider trading activity for Wynholds Kristin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Product Officer
Holding Value $2.6M 225,631 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$293k 25,362 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Product Officer
Holding Value $232k 225,631 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.1k 25,362 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
Chief Product Officer
Holding Value $2.35M 225,631 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 25,362 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
Chief Product Officer
Holding Value $22.6 225,631 shares
Last Trade
Dec 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.89k 25,362 shares
$0.23
$0.00
Better Therapeutics
Better Therapeutics MCAD
Chief Product Officer
Holding Value $2.09M 200,269 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 101,450 shares
$10.43
$10.43
Better Therapeutics
Better Therapeutics BTTX
Chief Product Officer
Holding Value $20 200,269 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.3k 101,450 shares
$0.90
$0.00
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Product Officer
Holding Value $2.31M 200,269 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 101,450 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Product Officer
Holding Value $206k 200,269 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 101,450 shares
$1.03
$1.03
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Product Officer
Holding Value $1.17M 101,450 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 101,450 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
Chief Product Officer
Holding Value $10.1 101,450 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 101,450 shares
$1.14
$0.00
Better Therapeutics
Better Therapeutics MCAD
Chief Product Officer
Holding Value $1.06M 101,450 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 101,450 shares
$10.43
$10.43
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Product Officer
Holding Value $104k 101,450 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 101,450 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
Chief Product Officer
Holding Value $1.03M 98,819 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.4k 3,781 shares
$10.43
$10.43
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Product Officer
Holding Value $102k 98,819 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.89k 3,781 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics BTTX
Chief Product Officer
Holding Value $9.88 98,819 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.52k 3,781 shares
$1.46
$0.00
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Product Officer
Holding Value $1.14M 98,819 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.6k 3,781 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Chief Product Officer
Holding Value $97.9k 95,038 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17k 5,023 shares
$1.03
$1.03
Better Therapeutics
Better Therapeutics MCAD
Chief Product Officer
Holding Value $991k 95,038 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.4k 5,023 shares
$10.43
$10.43
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Chief Product Officer
Holding Value $1.1M 95,038 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58k 5,023 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
Chief Product Officer
Holding Value $9.5 95,038 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.09k 5,023 shares
$1.81
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up